Dr. Michael C. Weiss

Fort Lauderdale, FL
Specialties:Orthopedics
OverviewInsuranceLocationsClinical Research

Overview

Michael Weiss is an Orthopedics provider in Fort Lauderdale, Florida. His top areas of expertise are Spinal Stenosis and Spondylolisthesis.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Orthopedics
Licenses
Orthopaedic Surgery of the Spine in FL
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Locations

1885 Marina Mile Blvd Ste 103, Fort Lauderdale, FL 33315
888-655-7473

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Enrollment Status: Completed
Publish Date: January 29, 2025
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase II Randomized, Placebo Controlled, Double-blind, Four Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Crohn's Disease
A Phase II Randomized, Placebo Controlled, Double-blind, Four Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Crohn's Disease
Enrollment Status: Completed
Publish Date: March 15, 2023
Intervention Type: Drug
Study Drug: SHR-0302 JAK Inhibitor
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology
Enrollment Status: Completed
Publish Date: December 24, 2019
Intervention Type: Device
View 8 Less Clinical Trials

2 Total Publications

Patient Outcomes After Minimally Invasive Excision of Lumbar Synovial Cysts, With and Without a Spondylolisthesis, in an Ambulatory Care Center Setting.
Patient Outcomes After Minimally Invasive Excision of Lumbar Synovial Cysts, With and Without a Spondylolisthesis, in an Ambulatory Care Center Setting.
Journal: International journal of spine surgery
Published: July 14, 2022
Similar Doctors
Expertise in
23
conditions
Dr. Francis J. Hornicek
Orthopedics
Expertise in
23
conditions
Dr. Francis J. Hornicek
Orthopedics

University Of Miami

1475 Nw 12th Ave, 
Miami, FL 
 (20.9 mi)
305-689-8648
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Francis Hornicek is an Orthopedics provider in Miami, Florida. Dr. Hornicek is highly rated in 23 conditions, according to our data. His top areas of expertise are Chordoma, Bone Tumor, Osteosarcoma, Osteotomy, and Bone Graft. Dr. Hornicek is currently accepting new patients.

Expertise in
9
conditions
Dr. Thomas J. Errico
Orthopedics
Expertise in
9
conditions
Dr. Thomas J. Errico
Orthopedics
3100 Sw 62nd Ave, 
Miami, FL 
 (25.4 mi)
305-666-6511
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Thomas Errico is an Orthopedics provider in Miami, Florida. Dr. Errico is highly rated in 9 conditions, according to our data. His top areas of expertise are Lordosis, Scoliosis, Kyphosis, Spinal Fusion, and Osteotomy. Dr. Errico is currently accepting new patients.

Expertise in
11
conditions
Dr. Jahangir K. Asghar
Orthopedics
Expertise in
11
conditions
Dr. Jahangir K. Asghar
Orthopedics

Elite Spine And Wellness, LLC

499 Nw 70th Ave, Suite 200, 
Plantation, FL 
 (6.2 mi)
954-223-5483
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jahangir Asghar is an Orthopedics provider in Plantation, Florida. Dr. Asghar is highly rated in 11 conditions, according to our data. His top areas of expertise are Scoliosis, Spinal Stenosis, Kyphosis, Spinal Fusion, and Microdiscectomy. Dr. Asghar is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile